Modified fixed-ratio isobologram method for studying in vitro interactions between atovaquone and proguanil or dihydroartemisinin against drug-resistant strains of Plasmodium falciparum

Antimicrobial Agents and Chemotherapy

Volumn 48, Issue 11, 2004, Pages 4097-4102

  Fivelman, Quinton L ^a   Adagu, Ipemida S ^a   Warhurst, David C ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; ATOVAQUONE PLUS PROGUANIL; DIHYDROARTEMISININ; PROGUANIL;

ANALYTIC METHOD; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG INHIBITION; IN VITRO STUDY; ISOBOLOGRAM; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TREATMENT FAILURE;

ANIMALS; ANTIMALARIALS; ARTEMISININS; ATOVAQUONE; CHLOROGUANIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; DRUG INTERACTIONS; DRUG RESISTANCE; DRUG SYNERGISM; NAPHTHOQUINONES; PLASMODIUM FALCIPARUM; REPRODUCIBILITY OF RESULTS; SESQUITERPENES;

EID: 7244240741     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.48.11.4097-4102.2004     Document Type: Article

References (31)

1. Bloland, P. B., M. Ettling, and S. Meek. 2000. Combination therapy for malaria in Africa: hype or hope? Bull. W. H. O. 78:1378-1388.
2. Canfield, C. J., M. Pudney, and W. E. Gutteridge. 1995. Interactions of atovaquone with other antimalarial drugs against Plasmodium falciparum in vitro. Exp. Parasitol. 80:373-381.
3. Chawira, A. N., and D. C. Warhurst. 1987. The effect of artemisinin combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. J. Trop. Med. Hyg. 90:1-8.
4. Chawira, A. N., D. C. Warhurst, B. L. Robinson, and W. Peters. 1987. The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice. Trans. R. Soc. Trop. Med. Hyg. 81:554-558.
5. Desjardins, R., C. Canfield, J. Haynes, and J. Chulay. 1979. Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob. Agents Chemother. 16:710-718.
6. Ekong, R., and D. C. Warhurst. 1990. Synergism between arteether and mefloquine or quinine in a multidrug-resistant strain of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 84:757-758.
7. Farnert, A., J. Lindberg, P. Gil, G. Swedberg, Y. Berqvist, M. M. Thapar, N. Lindegardh, S. Berezcky, and A. Bjorkman. 2003. Evidence of Plasmodium falciparum malaria resistant to atovaquone and proguanil hydrochloride: case reports. BMJ 326:628-629.
8. Fivelman, Q. L., G. A. Butcher, I. S. Adagu, D. C. Warhurst, and G. Pasvol. 2002. Malarone treatment failure and in vitro confirmation of resistance of Plasmodium falciparum isolate from Lagos, Nigeria. Malar. J. 1:1.
9. Fivelman, Q. L., J. C. Waiden, P. J. Smith, P. I. Folb, and K. I. Barnes. 1999. The effect of artesunate combined with standard antimalarials against chloroquine-sensitive and chloroquine-resistant strains of Plasmodium falciparum in vitro. Trans. R. Soc. Trop. Med. Hyg. 93:429-432.
10. Fry, M., and M. Pudney. 1992. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4′-chlorophenyl) cyclohexyl]-3-hydroxy- 1,4-naphthoquinone (566C80). Biochem. Pharmacol. 43:1545-1553.
11. Gupta, S., M. M. Thapar, W. H. Wernsdorfer, and A. Bjorkman. 2002. In vitro interactions of artemisinin with atovaquone, quinine, and mefloquine against Plasmodium falciparum. Antimicrob. Agents Chemother. 46:1510-1515.
12. Hall, M. J., R. F. Middleton, and D. Westmacott. 1983. The fractional inhibitory concentration (FIC) index as a measure of synergy. J. Antimicrob. Chemother. 11:427-433.
13. Hassan Alin, M., A. Bjorkman, and W. H. Wernsdorfer, 1999. Synergism of benflumetol and artemether in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 61:439-445.
14. Hogh, B., P. D. Clarke, D. Camus, H. D. Nothdurft, D. Overbosch, M. Gunther, I. Joubert, K. C. Kain, D. Shaw, N. S. Roskell, and J. D. Chulay. 2000. Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Lancet 356:1888-1894.
15. Jiang, J. B., G. Jacobs, D. S. Liang, and M. Aikawa. 1985. Qinghaosu-induced changes in the morphology of Plasmodium inui. Am. J. Trop. Med. Hyg. 34:424-428.
16. Kawai, S., S. Kano, and M. Suzuki. 1993. Morphologic effects of artemether on Plasmodium falciparum in Aotus trivirgatus. Am. J. Trop. Med. Hyg. 49:812-818.
17. Korsinczky, M., N. Chen, B. Kotecka, A. Saul, K. Rieckmann, and Q. Cheng. 2000. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob. Agents Chemother. 44:2100-2108.
18. Llanos-Cuentas, A., P. Campos, M. Clendenes, C. J. Canfield, and D. B. Hutchinson. 2001. Atovaquone and proguanil hydrochloride compared with chloroquine or pyrimethamine/sulfadoxine for treatment of acute Plasmadium falciparum malaria in Peru. Braz. J. Infect. Dis. 5:67-72.
19. Looareesuwan, S., J. D. Chulay, C. J. Canfield, and D. B. Hutchinson. 1999. Malarone (atovaquone and proguanil hydrochloride): a review of its clinical development for treatment of malaria. Am. J. Trop. Med. Hyg. 60:533-541.
20. Maeno, Y., T. Toyoshima, H. Fujioka, Y. Ito, S. R. Meshnick, A. Benakis, W. K. Milhous, and M. Aikawa. 1993. Morphologic effects of artemisinin in Plasmodium falciparum. Am. J. Trop. Med. Hyg. 49:485-491.
21. Martin, S. K., A. M. Oduola, and W. K. Milhous. 1987. Reversal of chioroquine resistance in Plasmodium falciparum by verapamil. Science 235:899-901.
22. Nosten, F., and P. Brasseur. 2002. Combination therapy for malaria: the way forward? Drugs 62:1315-1329.
23. Overbosch, D., H. Schilthuis, U. Bienzle, R. H. Behrens, K. C. Kain, P. D. Clarke, S. Toovey, J. Knobloch, H. D. Nothdurft, D. Shaw, N. S. Roskell, and J. D. Chulay. 2001. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin. Infect. Dis. 33:1015-1021.
24. Peters, W. 1999. The chemotherapy of rodent malaria. LVII. Drug combinations to impede the selection of drug resistance. Part 1. Which model is appropriate? Ann. Trop. Med. Parasitol. 93:569-587.
25. Srivastava, I. K., J. M. Morrisey, E. Barrouzet, F. Daldal, and A. B. Vaidva. 1999. Resistance mutations reveal the atovaquone-binding domain of cytochrome b in malaria parasites. Mol. Microbiol. 33:704-711.
26. Srivastava, I. K., H. Rottenberg, and A. B. Vaidya. 1997. Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malarial parasite. J. Biol. Chem. 272:3961-3966.
27. Srivastava, I. K., and A. B. Vaidya. 1999. A mechanism for the synergistic antimalarial action of atovaquone and proguanil. Antimicrob. Agents Chemother. 43:1334-1339.
28. Stahel, E., P. Druilhe, and M. Gentilini. 1988. Antagonism of chloroquine with other antimalarials. Trans. R. Soc. Trop. Med. Hyg. 82:221.
29. Trager, W., and J. B. Jensen. 1976. Human malaria parasites in continuous culture. Science 193:673-675.
30. White, N. J. 1998. Preventing antimalarial drug resistance through combinations. Drug Res. Updates 1:3-9.
31. White, N. J., F. Nosten, S. Looareesuwan, W. M. Watkins, K. Marsh, R. W. Snow, G. Kokwaro, J. Ouma, T. T. Hien, M. E. Molyneux, T. E. Taylor, C. I. Newbold, T. K. Ruebush, M. Danis, B. M. Greenwood, R. M. Andersen, and P. Olliaro. 1999. Averting a malaria disaster. Lancet 353:1965-1967.